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ÖZET
Bakteriyel iletişimin sisteminin (Quorum Sensing) 
kesilmesi: Bakteri aracılı hastalıklarla savaşta 
umut vaat eden yeni bir yol 
Antibiyotikler bakteriyel enfeksiyonların tedavisinde yaygın bir şekil-
de kullanılmaktadırlar. İlaç tedavisinde antibiyotiklerin gereksiz ve 
rastgele kullanımları, bu ajanlara karşı yaygın direnç gelişmesine 
neden olmuştur. Çoklu antibiyotik direncine sahip bakterilerin ortaya 
çıkması ve hızla yayılması, halihazırda mevcut antibiyotiklerle bakte-
riyel infeksiyonların tedavisini giderek güçleştirmektedir. Dolayısıyla, 
bakterilerle savaş yeteneğimizin azaldığı post-antibiyotik bir dönem-
le karşı karşıyayız ve infeksiyöz hastalıklarla başa çıkmak için yeni 
stratejilere olan gereksinim gün geçtikçe artmaktadır. Patojenik 
bakterilerin patojenite ve virülans faktörlerinin üretimini bakteriler 
arası iletişim sistemini kullanarak düzenlendiklerinin keşfi, bakteriler 
arası iletişim sistemini antimikrobiyal tedavi için cazip bir hedef hali-
ne getirmiştir. Bakterileri öldürmek yerine patogenezi hedef almak, 
direnç gelişimi için daha az seçici baskı uygulayabilir, bu nedenle 
bakteriyel iletişim inhibitörleri kullanarak bakteriler arası iletişimin 
inaktive edilmesi, infeksiyöz hastalıkların tedavisi için büyük umut 
vaat etmektedir.
Anahtar sözcükler: Hücreler arası iletişim, antibiyotik direnci, quo-
rum sensing inhibitörleri
ABS TRACT
Disruption of bacterial cell-to-cell communication 
(Quorum Sensing): a promising novel way to 
combat bacteria-mediated diseases
Antibiotics are commonly used for the treatment of bacterial 
infections. The inappropriate and indiscriminate application 
of antibiotics in pharmacotherapy has led to the development 
of widespread resistance to these agents. With the emergence 
and spread of multi antibiotic-resistant bacteria, it is becoming 
increasingly more difficult to treat bacterial infections with currently 
available antibiotics. Thus, we are facing a post-antibiotic era with a 
reduced capability to fight bacteria, and, hence, there is an increasing 
need for new strategies to cope with infectious diseases. The 
discovery that many pathogenic bacteria employ quorum sensing 
(QS) to regulate their pathogenicity and virulence factor production 
makes the QS system an attractive target for antimicrobial therapy. 
Targeting the pathogenesis instead of killing the organism may 
provide less selective pressure for the development of resistance. 
Therefore, it has been suggested that inactivating the QS system 
in bacteria by the use of QS inhibitors holds great promise for the 
treatment of infectious diseases. 
Key words: Cell-to-cell communication, antibiotic resistance, 
quorum sensing inhibitors
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 INTRODUCTION
 The discovery of antibiotics has been a milestone in the 
history of medicine. With the introduction of antibiotics into 
clinical practice, infectious diseases that were once 
untreatable have become treatable and millions of lives 
have been saved by taking many dangerous bacterial 
infections under control. However, this medical miracle is 
being deteriorated by the development and rapid spread of 
bacterial resistance (1). Today, a global concern has emerged 
that we are facing a post antibiotic era with a limited 
capability to fight bacterial infections (2). The increasing 
occurrence of multiantibiotic-resistant pathogen strains has 
gradually made conventional antimicrobial treatment 
ineffective. Thus, there is a great need to develop novel 
strategies to combat microbes without selecting for 
resistance. The discovery that many pathogenic bacteria 
employ bacterial cell-to-cell communication or quorum 
sensing (QS) system to regulate their pathogenicity and 
virulence factor production makes this system a novel 
therapeutic target for the design and development of a new 
class of drugs that potentially control pathogenicity and 
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attenuate virulence. Compounds capable of reducing 
bacterial virulence are termed antipathogenic drugs. 
Antipathogenic drugs target key regulatory mechanisms 
that control the expression of virulence factors in pathogenic 
bacteria and can render pathogenic bacteria non-virulent 
(3). In fact, this approach has already shown promise in the 
battle against human pathogen P. aeruginosa (2). 
 Quorum Sensing
 QS is a cell-to-cell communication system employed by 
a variety of Gram (-) and Gram (+) bacteria to coordinate 
group behaviors as function of cell-density. QS depends on 
the production of small signal molecules which enable a 
bacterium to monitor its own cell-density and coordinate 
critical gene expression (4). QS system was first described in 
the 1970s in the Gram (-) marine luminescent bacterium 
Vibrio fisheri (5). Long thought to be unique to Vibrio fisheri 
and certain closely related marine bioluminescent bacteria, 
it is now widely recognized that a variety of pathogenic 
bacteria use QS to control several processes including 
virulence factor production, antibiotic production, motility 
and the formation of biofilm (2,6). By perceiving the 
signaling molecules, bacteria can modulate above 
mentioned processes in a cell-density dependent manner. 
For example, in a bacterial infection, bacteria avoid 
producing and releasing virulence factors until they reach a 
critical population density and, by doing so, they ensure 
that they become numerous enough to overwhelm the 
host`s immune system (2). Several types of signaling 
molecules have been identified in the last two decades 
(Figure 1). N-acylated-L-homoserine lactones (AHLs) are the 
most common class of signaling molecules in Gram (-) 
bacteria, while autoinducing peptides (AIPs) are the major 
class of signaling molecules in Gram (+) bacteria. 
Autoinducer-2 (AI-2) is a third category of signaling 
molecules that is employed by both Gram (-) and Gram (+) 
bacteria and is believed to be used for intra- and inter-
species communication (7). In this paper, the current state 
of research concerning inhibition of acyl HSL-mediated QS 
in Gram (-) bacteria is reviewed.
 Ahl-Mediated Quorum Sensing
 Among QS signaling molecules, the most intensely 
studied signals are AHLs of Gram (-) bacteria. AHLs signalling 
was first described in Vibrio fisheri and has become a model 
for studies of QS. In many Gram (-) bacteria, AHL-based QS 
essentially involves the same series of events. The AHL 
Figure 1: QS signaling molecules utilized by various bacteria.
A) AHLs employed by Gram (-) bacteria. B) Oligopeptide employed 
by Gram (+) bacteria. C) Autoinducer-2 (AI-2) employed by both by 
Gram (-) and Gram (+) bacteria.
Figure 2: The regulation of bioluminescence in V. fisheri A) At low 
population density, luxR and luxI are transcribed at a low level and 
there is insufficient accumulation of OHHL. B) When the intracellular 
concentration of OHHL reaches a certain threshold, an OHHL-LuxR 
complex activates transcription of the luxICDABE operon resulting 
increased levels of OHHL and bioluminescence (8).
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signal is synthesized at low basal level by an enzyme (a LuxI-
type synthase). AHL signals diffuse out from bacterial cells 
and accumulate in the medium as a function of cell growth. 
At a threshold population density, the accumulated AHLs 
interact with a transcriptional activator protein (a LuxR-
type transcriptional regulator) which will then induce the 
expression of QS-regulated genes (Figure 2) (8). AHL-
mediated QS systems have been identified in human 
pathogens such as Pseudomonas aeruginosa (9), Yersinia 
pseudotuberculosis (10), Burkholderia cepacia (11), and 
Escherichia coli (12). 
 Quorum Sensing as a Target for Antimicrobial
 Therapy
 Conventional antibiotics work by either killing 
(bacteridicial) or inhibiting the growth of bacteria 
(bacteriostatic). However, this imposes hard the selective 
pressure for the development of antibiotic resistance. 
Therefore, alternative strategies to combat bacterial 
infections are needed more than ever. It has been observed 
that disrupting the QS system of a pathogen can result in a 
significant decrease in virulence factor production. For 
example, in human pathogen P. aeruginosa, QS is involved 
in the production of extracellular virulence factors such as 
elastase, protease, hemolysins, exotoxin A, rhamnolipid, 
pyocyanin, pyoverdin and formation of biofilms and their 
tolerance to antimicrobial agents (2,13-15). Importance of 
QS to establish a successful infection has been shown in 
number of different infection models such as mouse burn 
wound, pulmonary infection and keratitis by employing QS 
deficient strains (16,17). In these studies, inadequacy of QS 
deficient strains to establish successful infection was 
proposed to be associated with reduced production of 
virulence factors. In addition to virulence factor production, 
many pathogenic bacteria such as P. aeruginosa also employ 
QS to control the formation of biofilms (18,19). It has been 
estimated that bacterial biofilms are responsible for over 
80% of human infections (19-21). Biofilm-associated 
infections are very difficult to treat with traditional 
antibiotics as bacteria are embedded in an extracellular 
matrix composed of exopolysaccharides and proteins that 
reduce the contact between bacteria and antibacterial 
agent (21). Targeting the QS systems of pathogens is a novel 
plan of attack. Inhibitors and antagonists of bacterial QS 
might constitute a new generation of antimicrobial agents. 
Blocking of QS in bacteria by the use of QS inhibitors 
(antipathogenic drugs) may find applications in medicine, 
agriculture and food technology (2,22). The QS system can 
be interfered with in a number of ways, including (1) 
inhibition of AHL molecule biosynthesis, (2) degradation of 
AHL molecules by bacterial lactonases and (3) using small 
molecules to block the activation of AHL receptor protein 
(22,23). 
 QS Inhibitors
 Up to date, various types of screening have been 
carried out to find potential QS-inhibitory compounds. 
The first demonstration of QS inhibitors came from the 
Australian red macro alga Delisea pulchra. D. pulchra was 
found to produce a cocktail of halogenated furanone 
compounds some of which were able to inhibit QS. It was 
suggested that halogenated furonones inhibit AHL-
mediated gene expression by competitively binding to 
the AHL receptor site on the LuxR-type protein. Gram et al. 
(24) demonstrated the potential of pure samples of 
furonones in preventing swarming motility in Proteus 
mirabilis at concentrations that did not effect bacterial 
growth. The natural D. pulchra furanone compounds are 
unable to inhibit human pathogen P. aeruginosa QS 
systems. However, synthetic furonone derivatives showed 
significant anti-QS activity in P. aeruginosa (2,25). Natural 
or synthetic furanone compounds were also found to 
inhibit a range of QS regulated phenotypes in a variety of 
bacterial species including E. coli O157:H7 and Salmonella 
enterica serovar Typhimurium and Serratia liquefaciens 
(26,27). These results suggest that furanone compounds 
could serve as a source to develop furanone-based drugs 
to block quorum-sensing systems in many Gram (-) 
bacteria. In addition to furanones, a number of other 
compounds that modulate AHL-mediated QS in Gram (-) 
bacteria have been identified. A wide range of natural 
substances, particularly extracts from plants and fungi 
have been shown to modulate AHL-regulated phenotypes 
in Gram (-) bacteria. Plants like garlic, water lily, pea 
seedlings, vanilla, Medigo sativa, extracts of Tremella 
fuciformis, Panax ginseng, Scorzonera sandrasica, extracts 
of various medicinal plants from South Florida, clove oil 
and tannic acid are known to modulate AHL-mediated QS 
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systems (15,22,23,28-30). Yang et al. (29) discovered that 
chlorzoxazone, salicylic acid and nifuroxazide were 
capable of interfering with QS in P. aeruginosa. A range of 
recognized drugs have been shown to have quorum 
sensing inhibitory activities. For example, some macrolide 
and nonmacrolide antibiotics have been shown to have 
effects upon AHL-mediated QS in Gram-negative bacteria. 
Skindersoe et al. (31) identified that ceftazidime and 
iprofloxacin reduced QS-regulated gene expression in P. 
aeruginosa. The sub-inhibitory concentration of antibiotic 
tobramycin has been reported to reduce elastase 
production in P. aeruginosa (32). 
 CONCLUSIONS
 The extensive usage of antibiotics in pharmacotherapy 
has led to the development of widespread bacterial 
resistance to these agents. Hence, there is a rising need to 
find alternatives to currently available antibiotics. The 
disruption of QS systems of pathogenic bacteria has been 
regarded as the novel way to combat bacterial diseases. 
Inhibition of bacterial QS, rather than bactericidal or 
bacteriostatic strategies, offers a promising way to tackle 
the bacterial resistance problem. Because QS is not directly 
involved in processes essential for growth of bacteria, 
inhibition of QS should not impose harsh selective pressure 
for the development of resistance as with antibiotics. In 
addition, compounds that are capable of disrupting 
bacterial QS could potentially be used in combination with 
conventional antibiotics to increase the efficiency of disease 
control and to extend the life span of current antimicrobials. 
Over the course of the last 15 years, a large number of 
structurally diverse QS inhibitors have been discovered. Of 
the numerous molecules able to inhibit QS `in vitro`, a few 
have been successfully tested `in vivo` in animal models. 
Future work will reveal the possibility of using these QS 
inhibitors to treat bacterial infections in animals and 
humans.
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